Refocusing the brain: New approaches in neuroprotection against ischemic injury

[EN]A new era for neuroprotective strategies is emerging in ischemia/reperfusion. This has forced to review the studies existing to date based in neuroprotection against oxidative stress, which have undoubtedly contributed to clarify the brain endogenous mechanisms, as well as to identify possible t...

Descripción completa

Detalles Bibliográficos
Autores: Rodríguez González, Cristina, Agulla Freire, Jesús, Delgado Esteban, María
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Universidad de Salamanca (USAL)
Repositorio:GREDOS. Repositorio Institucional de la Universidad de Salamanca
OAI Identifier:oai:gredos.usal.es:10366/155415
Acceso en línea:http://hdl.handle.net/10366/155415
Access Level:acceso embargado
Palabra clave:Ischemic preconditioning
Neurons
Oxidative Stress
Brain Ischemia
Ischemic Preconditioning
Reactive Oxygen Species
Animals
Astrocytes
Humans
Gene Expression
Neuroprotective Agents
fármacos neuroprotectores
astrocitos
animales
humanos
estrés oxidativo
isquemia cerebral
neuronas
expresión génica
especies reactivas de oxígeno
preacondicionamiento isquémico
Descripción
Sumario:[EN]A new era for neuroprotective strategies is emerging in ischemia/reperfusion. This has forced to review the studies existing to date based in neuroprotection against oxidative stress, which have undoubtedly contributed to clarify the brain endogenous mechanisms, as well as to identify possible therapeutic targets or biomarkers in stroke and other neurological diseases. The efficacy of exogenous administration of neuroprotective compounds has been shown in different studies so far. However, something must be missing to get these treatments successfully applied in the clinical environment. Here, the mechanisms involved in neuronal protection against physiological level of ROS and the main neuroprotective signaling pathways induced by excitotoxic and ischemic stimuli are reviewed. Also, the endogenous ischemic tolerance in terms of brain self-protection mechanisms against subsequent cerebral ischemia is revisited to highlight how the preconditioning has emerged as a powerful tool to understand these phenomena. A better understanding of endogenous defense against exacerbated ROS and metabolism in nervous cells will therefore aid to design pharmacological antioxidants targeted specifically against oxidative damage induced by ischemic injury, but also might be very valuable for translational medicine.